Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma

Clinical trial NCT00871481 · COMPLETED

Trial details

NCT number: NCT00871481
Sponsor: Fred Hutchinson Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Melanoma Stage IV Melanoma

Start date: 2009-02-01
Primary completion: 2013-09-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.